May 23, 2017 / 7:26 AM / 2 months ago

BRIEF-Cadila Healthcare's Zydus gets final FDA nod for drug to treat allergy symptoms

1 Min Read

May 23 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus receives final approval from U.S. FDA for cyproheptadine hydrochloride tablets usp

* Drug intended to relieve allergy symptoms; to be produced at group's formulations manufacturing facility at Pharma SEZ in Ahmedabad Source text: bit.ly/2rOe3Lc Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below